An informal discussion with Dr. Paul Offit: recap

By -
Dr. Paul Offit stopped by PSPG to lead a discussion on snake oil and pseudoscience and how scientists can combat misinformation. An excellent example of this issue is the ubiquitous use of dietary supplements to treat everything from colds to weight loss to depression. Dietary supplements are not regulated by the FDA and are not rigorously tested for safety and efficacy and yet millions of Americans believe that multi-vitamins and supplements keep them healthy. These daily supplement capsules are packed with more vitamins than a person could possibly get from a normal diet, and yet there is no evidence that more is better. Because supplements are unregulated, what you see on the bottle is not necessarily what you get: there have been instances in which the supplement was actually 30x more concentrated than what the label claimed, and there have been cases of contaminated supplements causing death. So why is the general public so easily fooled? Because they believe they're ingesting "natural" alternative homeopathic remedies, rather than drugs which could have side effects, when in reality these supplements are drugs themselves made by the very pharmaceutical companies people are sticking it to. How can we as scientists combat this false narrative? Dr. Offit suggests to first use evidence-based science, and if all else fails appeal to emotion. In an ideal world, facts, evidence and reason would be enough to convince people, but unfortunately that is not the world we live in.

Dr. Offit is the author of numerous books his latest being Deadly Choices: How the Anti-Vaccine Movement Threatens Us All and Do You Believe in Magic?: The Sense and Nonsense of Alternative Medicine.

 Check out Dr. Offit on the Colbert Report in 2011!

Comments

Post a Comment

Popular posts from this blog

2015 AAAS Science and Technology Policy Forum Summary

By -
I recently had the opportunity to attend the 2015 AAAS Science and Technology Policy Forum in Washington, D.C. This annual meeting brings together a range of academics and professionals to discuss the broad S&T policy landscape. Below are some of my takeaways from the meeting. I hope to have additional comments from other National Science Policy Group members up soon. By Chris Yarosh The talks and panels at the Forum encompassed a huge range of topics from the federal budget and the appropriations outlook to manufacturing policy and, of course, shrimp treadmills . My opinion of the uniting themes tying this gamut together is just that—my opinion— and should only be taken as such. That being said, the threads I picked on in many of the talks can be summarized by three C’s: cooperation, communication, and citizenship . First up, cooperation. Although sequestration’s most jarring impacts have faded, AAAS’s budget guru Matthew Hourihan warns that fiscal year 2016 could ...
Read more

AAAS Forum Take #2

By -
Another point of view of the AAAS Forum by Matthew Facciani: I have provided scientific testimony and met with some of my local legislators, but I’ve never had any formal exposure to science policy. I was really excited to hear about the AAAS Science & Technology Policy Forum to learn more about how scientists can impact policy. The information I absorbed at the conference was overwhelming, but incredibly stimulating. Some of the lectures discussed the budget cuts and the depressing barriers for achieving science policy. However, I felt there was definitely an atmosphere of optimism at the conference and it was focused on how we can create positive change. One of my favorite aspects of the conference were the discussions of how to effectively communicate science to non-scientists. Before we can even have discussions of funding, the general public needs to understand how science works and why basic science is so important. For example, science never proves anything with 100%...
Read more

Dr. Sarah Cavanaugh discusses biomedical research in her talk, "Homo sapiens: the ideal animal model"

By -
Image
Biology and preclinical medicine rely heavily upon research in animal models such as rodents, dogs, and chimps. But how translatable are the findings from these animal models to humans? And what alternative systems are being developed to provide more applicable results while reducing the number of research animals? Image courtesy of PCRM Last Thursday, PSPG invited Dr. Sarah Cavanaugh from the Physicians Committee for Responsible Medicine to discuss these issues. In her talk entitled, “ Homo sapiens : the ideal animal model,” she emphasized that we are not particularly good at translating results from animal models into human patients. Data from the FDA says that 90% of drugs that perform well in animal studies fail when tested in clinical trials.  It may seem obvious, but it is important to point out that the biology of mice is not identical to human biology. Scientific publications have demonstrated important dissimilarities in regards to the pathology of inflammation...
Read more